Abstract-Inflammatory responses play an important role in atherosclerosis. To critically assess the effect of dihydropyridines in inflammatory reactions, we conducted a monocyte-endothelial adhesion assay with monocytic THP-1 cells treated with amlodipine under flow conditions in vitro. THP-1 cells were incubated in the presence of amlodipine (10 mol/L) for 48 hours and then perfused over activated (interleukin-1, 10 U/mL, 4 hours) human umbilical vein endothelial cells. The adhesion of THP-1 cells was significantly reduced after amlodipine treatment (PϽ0.001); however, flow cytometric analysis reveled that the expression levels of integrins in THP-1 cells were not significantly altered. Furthermore, Western blotting analysis of THP-1 cell lysates revealed that translocation of RhoA from the cytosol to the membrane was significantly diminished after amlodipine treatment. In addition, activation of protein kinase C-␣ and -, as well as intracellular calcium influx, induced by phorbol 12-myristate 13-acetate, was diminished after amlodipine treatment. Pretreatment of THP-1 cells with calphostin C, a potent inhibitor of protein kinase C, significantly reduced THP-1 adhesion to vascular endothelium, whereas activation of  1 -integrin was reduced after amlodipine treatment in THP-1 cells, based on the immunoreactivity of an activation-specific antibody for  1 -integrin. Similar inhibitory effects were observed when we used freshly isolated peripheral blood mononuclear cells. These findings suggest a potential role for amlodipine in monocyte-endothelial interactions by modulation of protein kinase C-and RhoA-dependent mechanisms, which might account for its vascular protective effects. Key Words: calcium channel blockers Ⅲ cell adhesion molecules Ⅲ monocytes Ⅲ protein kinases Ⅲ signal transduction L -type calcium channel antagonists are widely used in the management of hypertension as well as coronary heart diseases, and an increasing number of reports support the therapeutic benefits of these compounds for patients with cardiovascular diseases. Recently, amlodipine, a Ca 2ϩ channel blocker, was shown to reduce the progression of atherosclerotic plaque formation in rabbit models, 1,2 suggesting its role in atherosclerosis. In one of those studies, amlodipine caused a significant and dose-dependent reduction in lesion formation in the thoracic aorta, 1 whereas in another, it exhibited an atheroprotective effect by acting as an antioxidant and reducing LDL uptake by the vessel wall, which consequently limited the size and extent of lesional areas. 3 These two findings have been proposed to show potential mechanisms for the antiatherosclerotic effect of amlodipine. In addition to those findings, the results of several in vitro studies also indicate that treatment with amlodipine enhances nitric oxide production in endothelial cells, 4 suggesting an anti-inflammatory role for the compound. In the present study, we attempted to elucidate the molecular mechanism responsible for the anti-inflammatory role of amlodipine by...